EP2882406A2 - Agents de soins capillaires contenant des silicones choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques - Google Patents

Agents de soins capillaires contenant des silicones choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques

Info

Publication number
EP2882406A2
EP2882406A2 EP13734093.1A EP13734093A EP2882406A2 EP 2882406 A2 EP2882406 A2 EP 2882406A2 EP 13734093 A EP13734093 A EP 13734093A EP 2882406 A2 EP2882406 A2 EP 2882406A2
Authority
EP
European Patent Office
Prior art keywords
acid
polyquaternium
branched
weight
hair treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP13734093.1A
Other languages
German (de)
English (en)
Inventor
Marcus Krueger
Jörg KAHRE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2882406A2 publication Critical patent/EP2882406A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Definitions

  • the present invention relates to hair treatment compositions containing a synergistic combination of selected silicones and selected complexes of acidic protein hydrolysates and basic fatty acid amidoamines.
  • a care complex should be provided which can ideally also be used in conjunction with oxidizing agents and surface-active agents.
  • the oxidative treatment keratin braver fibers, especially human hair with the application of an effective fiber protection from environmental influences, such as UV protection, are connected.
  • Fatty acid amidoamines and protein hydrolysates are in principle known chemical compounds and are also already used in hair care products as ingredients. Also known are silicones in hair treatment products. They are often used to improve the properties of the hair. However, these known compositions can not satisfactorily solve the problems. Insofar as the active ingredient complex is discussed below, this statement refers to the ingredients a) and b) which are mandatory in the hair treatment compositions according to the invention.
  • a first object of the present invention is therefore a hair treatment composition containing - based on its weight - a) at least one silicone compound in a total amount of 0.01 to 95.0 wt.% Based on the total composition and
  • the cosmetic agents are used to treat keratinous fibers, in particular human hair.
  • Preferred agents according to the invention are therefore, for example, shampoos, hair dyes, conditioners or hair tonics.
  • the grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.
  • Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.
  • an oxidative cosmetic agent containing at least one oxidizing agent on hair in a cosmetic carrier is defined according to the invention.
  • the hair treatment composition comprising the active substance complex according to the invention is preferably used immediately before, during or after the oxidative or surfactant hair treatment.
  • an application directly followed by the oxidative or surfactant hair treatment wherein the active ingredient complex containing hair treatment agent previously rinsed from the hair or preferably left on the hair and the hair is preferred still wet.
  • the hair treatment agent is applied after rinsing the oxidative or surfactant acting on the preferably still wet, towel-dried hair, or only after several hours or days on the dry or wet hair is applied.
  • the hair treatment composition according to the invention can be rinsed out again after a contact time of a few seconds up to 45 minutes or remain completely on the hair.
  • the effect of the hair treatment agent according to the invention unfolds even during the oxidative or surfactant hair treatment and surprisingly persists even after intensive washing out of the hair treatment composition according to the invention.
  • the active substance complex according to the invention is preferably used in a cosmetic carrier.
  • the cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
  • An aqueous cosmetic carrier contains at least 50% by weight of water.
  • aqueous-alcoholic cosmetic carriers include aqueous solutions containing 3 to 70% by weight of a C 1 -C 6 -alcohol, in particular methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-pentanol , Iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or 1, 6-hexanediol to understand.
  • the compositions of the invention may additionally contain other organic solvents, such as methoxybutan
  • the first essential ingredient a) in the hair treatment compositions is at least one silicone.
  • the silicone according to the invention is selected from aminofunctional silicones, dimethicones, dimethiconols, water-soluble silicones, cyclomethicones and any mixtures of these silicones.
  • Aminofunctional silicones may e.g. by the formula (Si-2)
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6
  • Q is a polar radical of the general formula -R HZ
  • R is a divalent linking group bonded to hydrogen and the radical Z composed of carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and
  • Z is an organic, amino-functional group containing at least one amino-functional group
  • b takes values in the range of about 1 to about 3,
  • a + b is less than or equal to 3
  • c is a number in the range of about 1 to about 3
  • x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and
  • y is a number in the range of from about 20 to about 10,000, preferably from about 125 to about
  • M is a suitable silicone end group, as is known in the art, preferably trimethylsiloxy.
  • Z is according to formula (Si-2) an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for said Z is NH (CH 2 ) z NH 2 , where z is an integer greater than or equal to 1.
  • Another possible formula for said Z is -NH (CH 2 ) Z (CH 2 ) z Z NH, wherein both z and zz are independently an integer greater than or equal to 1, this structure comprising diamino ring structures, such as piperazinyl , Said Z is most preferably an -NHCH 2 CH 2 NH 2 radical.
  • Z is - N (CH 2 ) Z (CH 2 ) ZZ NX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.
  • Q according to formula (Si-2) is most preferably a polar amino-functional radical of formula - CH 2 CH 2 CH 2 NH 2 CH 2 CH 2 NH 2 .
  • ⁇ assumes values in the range of 0 to 2
  • b takes values in the range of 2 to 3
  • a + b is less than or equal to 3
  • c is a number in the range of 1 to 3.
  • cationic silicone oils such as, for example, the commercially available products Dow Corning (DC) 929 Emulsion, DC 2-2078, DC 5-71 13, SM-2059 (General Electric) and SLM-55067 (Wacker).
  • Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si 3-a)
  • n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration and are available, for example, under the name Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone).
  • compositions according to the invention which contain at least one amino-functional silicone of the formula (Si-3b) R- [Si (CH3) 2-0] n1 [Si (R ') - 0] m - [Si (CH 3) 2-0] n2 SiMe 2 R (Si-3b),
  • R is -OH, a (optionally ethoxylated and / or propoxylated) (Ci to C 20 ) -
  • R ' is -OH, a (Ci to C 20 ) -alkoxy group or a -CH 3 -group and
  • n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2000, preferably between 50 and 150, the sum (n1 + n2) preferably having values from 0 to 1999 and in particular from 49 to 149 and m preferably values of
  • silicones are referred to the INCI declaration as amodimethicones, or as functionalized amodimethicones, such as bis (C13-15 alkoxy) PG amodimethicone (for example, as a commercial product: DC 8500 Dow Corning available).
  • Suitable diquaternary silicones are selected from compounds of the general formula (Si3c)
  • R 1 to R 6 independently of one another are C 1 to C 22 -alkyl radicals, which
  • At least one of the radicals has at least 8 C atoms and the remaining radicals have 1 to 4 C atoms,
  • radicals R 7 to R 12 independently of one another, are identical or different and are C 1 - to C 10 -alkyl or phenyl,
  • A is a divalent organic compound group
  • n is a number from 0 to 200, preferably from 10 to 120, more preferably from 10 to 40, and X "is an anion.
  • the divalent linking group is preferably a C1 to C12 alkylene or alkoxyalkylene group which may be substituted with one or more hydroxyl groups. Particularly preferred is the group - (CH 2 ) 3 -O-CH 2 -CH (OH) -CH 2 -.
  • the anion X " may be a halide ion, an acetate, an organic carboxylate or a compound of general formula RSO 3 " , wherein R has the meaning of C1 to C4 alkyl radicals.
  • a preferred diquaternary silicone has the general formula (Si3d)
  • A is the group - (CH 2 ) 3 - O - CH 2 - CH (OH) - CH 2 -,
  • R is an alkyl radical having at least 8 C atoms and n is a number from 10 to 120.
  • Suitable silicone polymers having two terminal quaternary ammonium groups are among
  • Hair-treatment agents preferred according to the invention are characterized in that, based on their weight, they are 0.01 to 10% by weight, preferably 0.01 to 8% by weight, especially preferably from 0.1 to 7.5% by weight and in particular from 0.2 to 5% by weight of amino-functional silicone (s) and / or diquaternary silicone.
  • polyammonium-polysiloxane compounds Another amino-functional silicone of the present invention are polyammonium-polysiloxane compounds.
  • the polyammonium-polysiloxane compounds can be obtained, for example, under the trade name Baysilone® from GE Bayer Silicones.
  • Baysilone TP 3911, SME 253 and SFE 839 are preferred. Very particular preference is given to the use of Baysilone TP 3911 as the active component of the compositions according to the invention.
  • the polyammonium-polysiloxane compounds are used in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.01 to 7.5, particularly preferably from 0.01 to 5.0% by weight, very particularly preferably from 0 , 05 to 2.5 wt.% Each used in relation to the total composition.
  • EP 1887024 A1 describes novel cationic amino-functional silicones which in particular improve the gloss in agents for the care of surfaces, for example human hair.
  • These cationic silicone polymers are characterized in that they have a silicone backbone and at least one polyether part and furthermore at least one part with an ammonium structure.
  • Examples of the preferred cationic silicone polymers for the purposes of the present invention are, in addition to the compounds of the aforementioned EP 1887024 A1, in particular the compounds with the INCI names: Silicone Quaternium-1, Silicone Quaternium-2, Silicone Quaternium-3, Silicone Quaternium-4 Silicone Quaternium-5, Silicone Quaternium-6, Silicone Quaternium-7, Silicone Quaternium-8, Silicone Quaternium-9, Silicone Quaternium-10, Silicone Quaternium-11, Silicone Quaternium-12, Silicone Quaternium-15, Silicone Quaternium-16 , Silicone Quaternium-17, Silicone Quaternium-18, Silicone Quaternium-20, Silicone Quaternium-21, Silicone Quaternium-22 as well as Silicone Quaternium-2 Panthenol Succinate and Silicone Quaternium-16 / Glycidyl Dimethicone Crosspolymer. Most preferred is Silicone Quaternium-22. This raw material is
  • a last particularly preferred amino silicone according to the invention corresponds to the following formula:
  • R 1 is a methyl, ethyl, hydroxyl, methoxy or ethoxy group
  • R 2 is a straight-chain or branched C 8 to C 24 alkyl or alkylene radical, preferably a straight-chain or branched C 9 to C 22 alkyl or alkenyl radical, more preferably a straight-chain or branched C 1 to C 18 alkyl or alkenyl radical, most preferably a corresponding alkyl radical,
  • n and m are each integers from 1 to 1000, and each q is an integer from 2 to 50, preferably 4 to 30, more preferably 4 to 18 and most preferably 4 to 12.
  • the molecular weight of such compounds is 15,000 to 2,000,000, as measured on a Brookfield RV rotary viscometer, spindle 5, at 20 ° C.
  • the molecular weight is 30,000 to 1,775,000, and more preferably 50,000 to 1,500,000.
  • the nitrogen content of the silicones of the invention is 0.03 to 4.2 wt.%, Preferably 0, 1 to 2.8 wt.% And most preferably 0, 16 to 1, 4 wt.%.
  • Amino-functional cationic silicones of the above formula according to the invention can be obtained, for example, from Clariant.
  • An inventively most preferred product is commercially available under the INCI name "Trideceth-9-Amodimethicone and Trideceth-12".
  • the cationic amino-functional silicone polymers of the formula described above are present in the compositions according to the invention in amounts of from 0.01 to 5% by weight, preferably in amounts of from 0.05 to 5% by weight and very particularly preferably in amounts of from 0.1 to 5% by weight .% contain. The very best results are obtained with amounts of 0, 1 to 2.5 wt.%, In each case based on the total composition of the respective agent.
  • the cationic amino-functional silicone polymers are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably in amounts of from 0.05 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. contain. The very best results are obtained with amounts of 0, 1 to 5 wt.%, In each case based on the total composition of the respective agent.
  • the dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethicones can be represented by the following structural formula (Si l):
  • Branched dimethicones can be represented by the structural formula (Sil 1):
  • the radicals R and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of the dimethicones are between 1000 D and 10,000,000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 ° C. with the aid of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970.
  • Preferred viscosities are between 1,000 and 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps. Most preferred are viscosities around the range of about 60,000 cps.
  • Particularly preferred cosmetic or dermatological preparations according to the invention are characterized in that they contain at least one silicone of the formula (Sil .2)
  • x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.
  • the dimethicones (Sil) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5 wt.% Based on the total composition.
  • the dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethiconols can be represented by the following structural formula (Si8-1):
  • Branched dimethiconols can be represented by the structural formula (Si8 - II):
  • the radicals R and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of the dimethiconols are between 1000 D and 10,000,000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 ° C Assistance of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 dated July 20, 1970.
  • Preferred viscosities are between 1,000 and 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cPs. The most preferred range is between 50,000 and 2,000,000 cps.
  • Examples of such products include the following commercial products: Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Coming 2-9026 Fluid, Abil OSW 5 (Degussa Care Specialties), Dow Coming 1401 Fluid, Dow Coming 1403 Fluid Dow Corning 1501 Fluid, Dow Corning 1784 HVF Emulsion, Dow Corning 9546 Silicone Elastomer Blend, SM555, SM2725, SM2765, SM2785 (all four aforementioned GE Silicones), Wacker-Belsil CM 1000, Wacker-Belsil CM 3092, Wacker-Belsil CM 5040, Wacker-Belsil DM 3096, Wacker-Belsil DM 31 12 VP, Wacker-Belsil DM 8005 VP, Wacker-Belsil DM 60081 VP (all Wacker-Chemie GmbH mentioned above).
  • the dimethiconols (Si8) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of dimethiconol based on the composition.
  • cyclic dimethicones designated as cyclomethicones according to INCI are also preferably used according to the invention.
  • cosmetic or dermatological preparations according to the invention are preferred which contain at least one silicone of the formula (Si-4)
  • x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.
  • Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula (Si-5)
  • R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH 2 -CH (CH 3 ) Ph, the Ci -2 o-alkyl radicals, preferably -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 H 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , - C (CH 3 ) 3 , x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, stand and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6.
  • water-soluble silicones may be present in the compositions according to the invention.
  • Corresponding hydrophilic silicones are selected, for example, from the compounds of the formulas (Si-6) and / or (Si-7).
  • Particularly preferred water-soluble silicone-based surfactants are selected from the group of dimethicone copolyols which are preferably alkoxylated, in particular polyethoxylated or polypropoxylated.
  • Dimethicone copolyols are understood according to the invention as meaning preferably polyoxyalkylene-modified dimethylpolysiloxanes of the general formulas (Si-6) or (Si-7):
  • radical R represents a hydrogen atom, an alkyl group having 1 to 12 C atoms, an alkoxy group having 1 to 12 C atoms or a hydroxyl group
  • radicals R 'and R denote alkyl groups having 1 to 12 C atoms
  • x is an integer from 1 to 100, preferably from 20 to 30
  • y is an integer from 1 to 20, preferably from 2 to 10
  • a and b are integers from 0 to 50, preferably from 10 to 30 ,
  • dimethicone copolyols according to the invention are, for example, the products sold commercially under the trade names SILWET (Union Carbide Corporation) and DOW CORNING.
  • Particularly preferred dimethicone copolyols according to the invention are Dow Corning 190 and Dow Corning 193.
  • the dimethicone copolyols are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight. % of dimethicone copolyol based on the composition.
  • the second obligatory component b) of the active substance complex is an ionic complex consisting of an acidic protein hydrolyzate and a basic fatty acid amidoamine.
  • an acidic protein hydrolyzate is preferably understood to mean a vegetable protein hydrolyzate.
  • the protein hydrolyzate moiety can be from any protein source.
  • vegetable protein hydrolysates such as soybean, almond, pea, moringa, potato and wheat protein hydrolysates.
  • Collagen hydrolysates of Fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates are also included in the invention.
  • the proportion of acidic amino acids in the hydrolyzate is at least 10% by weight, preferably 20% by weight, more preferably 30% by weight and most preferably 40% by weight.
  • Protein hydrolysates satisfying this condition form the ionic complexes of an acidic protein hydrolyzate and a basic fatty acid amidoamine of the present invention.
  • Protein hydrolysates based on elastin, collagen, keratin, silk and milk proteins are also possible according to the invention, although not preferred.
  • Suitable fatty acid amidoamines are any fatty acid amidoamine having a chain length of 8 to 40 carbon atoms in the chain.
  • the fatty acid amidoamines can be saturated or unsaturated, straight-chain or branched.
  • the fatty acid amidoamines according to the invention preferably fulfill the following structure:
  • R 1 is a linear or branched, saturated or unsaturated acyl radical having 8 to 40 carbon atoms in the chain
  • R 2 is a C 1 to C 4 alkyl radical or hydrogen
  • R 3, R 4 and R 5 are each independently hydrogen, a methyl radical or a C2 to C4 alkyl radical
  • n is an integer selected from 1, 2, 3, 4 or 5.
  • R2 means a methyl or ethyl radical
  • R 1 preferably represents one of the radicals caprinoyl, lauroyl, myristoyl, palmitoyl, stearoyl, oleoyl, linoloyl, arachinoyl, cetyloyl, behenoyl, eicosanoyl and / or 18-methyl eicosanoyl.
  • the carboxy terminal end of the acidic protein hydrolysates forms an ionic complex with the cationic or cationizable C8 to C40 fatty acid amidoamine.
  • Examples of such compounds are under the INCI name Cetearamidoethyl Diethonium Hydrolyzed Protein on the basis of wheat or rice commercially under the names Vegetamid® 18MEA R (Cetearamidoethyl Diethonium Hydrolyzed Rice) and Vegetamid® 18MEA G (Cetearamidoethyl Diethonium Hydrolyzed Wheat) of the Company Seiwa Kasei available.
  • the ionic complexes according to the invention of an acidic protein hydrolyzate and a fatty acid amidoamine are present in the compositions according to the invention in an amount of from 0.01 to 10.0% by weight, preferably from 0.01 to 7.5% by weight, more preferably from 0.1 to 5.0% by weight with respect to the entire composition.
  • Quaternary ammonium compounds are in principle monomeric cationic or amphoteric ammonium compounds, monomeric amines, aminoamides, polymeric cationic ammonium compounds and polymeric amphoteric ammonium compounds.
  • the following groups have proven to be particularly suitable for this variety of possible quaternary ammonium compounds and are used in each case in an amount of 0.1 to 15.0% by weight. This amount is also not exceeded or exceeded when a mixture of different compounds of the quaternary ammonium compounds is used.
  • Cationic surfactants of the formula (Tkat1-1) form the first group of cationic surfactants.
  • R 1, R 2, R 3 and R 4 each independently represent hydrogen, a methyl group, a phenyl group, a benzyl group, a saturated, branched or unbranched alkyl group having a chain length of 8 to 30 carbon atoms, optionally with a or multiple hydroxy groups.
  • A is a physiologically acceptable anion, for example halides such as chloride or bromide and methosulfates.
  • Examples of compounds of the formula (Tkat1) are lauryltrimethylammonium chloride, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, cetyltrimethylammonium methosulfate, dicetyldimethylammonium chloride, tricetylmethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylbenzylammonium chloride, behenyltrimethylammonium bromide, behenyltrimethylammonium bromide, behenyltrimethylammonium methosulfate.
  • Esterquats according to the formula (Tkat2) form a preferred group.
  • radicals R1, R2 and R3 are each independently and may be the same or different.
  • the radicals R1, R2 and R3 mean:
  • branched or unbranched alkyl radical having 1 to 4 carbon atoms, which may contain at least one hydroxyl group, or
  • the rest - (X - R4) is contained at least 1 to 3 times.
  • n 1 to 200, preferably 1 to 100, particularly preferably 1 to 50, and particularly preferably 1 to 20 with R 5 in the meaning of hydrogen, methyl or ethyl,
  • hydroxyalkyl group of one to four carbon atoms which may be branched or unbranched, and which contains at least one and at most 3 hydroxy groups.
  • Examples are: -CH 2 OH, -CH 2 CH 2 OH, -CHOHCHOH, -CH 2 CHOHCH 3 , -CH (CH 2 OH) 2 , -COH (CH 2 OH) 2 , -CH 2 CHOHCH 2 OH, CH 2 CH 2 CH 2 OH and hydroxybutyl radicals,
  • R6-0-CO- wherein R6 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and or 1 to 100 propylene oxide units may be ethoxylated, or
  • R 7 -CO- wherein R 7 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units can be ethoxylated,
  • A represents a physiologically acceptable organic or inorganic anion and is defined here as representative of all structures also described below.
  • the anion of all described cationic compounds is selected from the halide ions, fluoride, chloride, bromide, iodide, sulfates of the general formula RSO 3 " , wherein R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, or anionic radicals of organic acids such as Maleate, fumarate, oxalate, tartrate, citrate, lactate or acetate.
  • Such products are marketed under the trademarks Rewoquat ®, Stepantex® ®, Dehyquart® ®, ® and Armocare® Akypoquat ®.
  • the products Armocare ® VGH-70, Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80, Dehyquart ® F-30, Dehyquart ® AU-35, Rewoquat ® WE18, Rewoquat ® WE38 DPG, Stepantex ® VS 90 and Akypoquat ® 131 are examples of these esterquats.
  • R8 corresponds in its meaning R7.
  • esterquats with tradenames Armocare ® VGH-70 are, as well as Dehyquart ® F-75, Dehyquart ® L80, Stepantex ® VS 90 and Akypoquat ® 131st
  • cationic surfactants of the formula (bl) are used within narrower ranges, so that preferred hair treatment compositions according to the invention are characterized in that they are 0.1 to 15 wt .-%, preferably 0.5 to 10 wt .-%, further preferably 1 to 10 wt .-%, still more preferably 1, 5 to 10 wt .-% and in particular 2 to 5 wt .-% of at least one compound of the general formula (I).
  • R and R ' are independently selected from -H and -CH 3 ;
  • X- a physiologically acceptable anion, a halide such as chloride,
  • Inventive preferred hair treatment compositions are therefore characterized in that they additionally contain 0, 1 to 10 wt .-% of at least one compound of formula (II)
  • Tkat2 Another group are quaternary imidazoline compounds.
  • the formula (Tkat2) shown below shows the structure of these compounds.
  • the radicals R independently of one another each represent a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms.
  • the preferred compounds of the formula (Tkat2) contain for R the same hydrocarbon radical.
  • the chain length of the radicals R is preferably 12 to 21 carbon atoms.
  • A is an anion as previously described. Examples according to the invention are available, for example, under the INCII names Quaternium-27, Quaternium-72, Quaternium-83 and Quaternium-91. Quaternium 91 is highly preferred according to the invention.
  • compositions according to the invention furthermore comprise at least one amine and / or cationized amine, in particular an amidoamine and / or a cationized amidoamine having the following structural formulas:
  • R1 is an acyl or alkyl radical having 6 to 30 carbon atoms, which may be branched or unbranched, saturated or unsaturated, and wherein the acyl radical and / or the alkyl radical may contain at least one OH group, and
  • R2, R3 and R4 are each independently
  • hydroxyalkyl group having one to 4 carbon atoms having at least one and at most three hydroxy groups, for example -CH 2 OH, -CH 2 CH 2 OH, -CHOHCHOH, -CH 2 CHOHCH 3 , -CH (CH 2 OH) 2 , -COH (CH 2 OH) 2 ,
  • A is an anion as previously described and
  • n is an integer between 1 and 10.
  • R1 is a branched or unbranched, saturated or unsaturated acyl radical having 6 to 30 carbon atoms, which may contain at least one OH group means.
  • amidoamines and / or quaternized amidoamines in which R 2, R 3 and / or R 4 in the formula (Tkat3) represent a radical according to the general formula CH 2 CH 2 OR 5, where R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms , Hydroxyethyl or hydrogen.
  • the preferred size of n in the general formula (Tkat8) is an integer between 2 and 5.
  • the alkylamidoamines can both be present as such and converted by protonation in a correspondingly acidic solution into a quaternary compound in the composition. According to the invention, the cationic alkylamidoamines are preferred.
  • Witcamine ® 100 Incromine ® BB, Mackine ® 401 and other Mackine ® grades, Adogen ® S18V, and as a permanent cationic aminoamines: Rewoquat ® RTM 50, Empigen ® CSC, Swanol ® Lanoquat DES-50, Rewoquat ® UTM 50, Schercoquat® ® BAS ® Lexquat AMG-BEO, or Incroquat ® behenyl HE.
  • Another fatty acid amide according to the invention corresponds to the general formula (I).
  • R1, R2 and R3 independently of one another represent a linear branched or unbranched C6 to C30, preferably C8 to C24, more preferably C12 to C22 and most preferably C12 to C18 alkyl or alkenyl group.
  • R1 to R3 are preferably capryl, caprylyl, octyl, nonyl, decanyl, lauryl, myristyl, cetyl, stearyl, isostearyl, oleyl, behenyl or arachidyl.
  • R 2 is more preferably equal to R 3 and most preferably R 1 is R 2 equal to R 3.
  • the most preferred compound of formula (I) is that which carries the INCI name bis-ethyl (isostearylimidazoline) isostearamides. The latter compound is commercially available under the tradename Keradyn® HH from Croda.
  • the abovementioned cationic surfactants can be used individually or in any desired combinations with one another, with amounts of from 0.01 to 10% by weight, preferably from 0.01 to 7.5% by weight, and very particularly preferably from 0 to 0, 1 to 5.0% by weight. The very best results are obtained with amounts of 0, 1 to 3.0 wt.%, Based in each case on the total composition of the respective agent.
  • quaternary ammonium compounds are cationic and amphoteric polymers.
  • the cationic and / or amphoteric polymers may be homopolymers or copolymers or polymers based on natural polymers, wherein the quaternary nitrogen groups are contained either in the polymer chain or preferably as a substituent on one or more of the monomers.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable cationic monomers are unsaturated, free-radically polymerizable compounds which carry at least one cationic group, in particular ammonium-substituted vinyl monomers such as, for example, trialkylmethacryloxyalkylammonium, trialkylacryloxyalkylammonium, dialkyldiallylammonium and quaternary
  • Vinyl ammonium monomers with cyclic, cationic nitrogen-containing groups such as pyridinium, imidazolium or quaternary pyrrolidones, e.g. Alkylvinylimidazolium, Alkylvinylpyridinium, or Alyklvinylpyrrolidon salts.
  • the alkyl groups of these monomers are preferably lower alkyl groups such as C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkylacrylate, alkylmethacrylate, vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinylester, e.g. Vinyl acetate, vinyl alcohol, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • R -H or -CH 3 , R 2 , R 3 and R 4 are independently selected from C1-4-
  • Alkyl, alkenyl or hydroxyalkyl groups, m 1, 2, 3 or 4, n is a natural number and
  • Polymers are those inventively preferred for which at least one of the following Conditions are: R is a methyl group, R 2 , R 3 and R 4 are methyl groups, m is 2.
  • Suitable physiologically tolerated counterions X " include, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ion. Preference is given to methosulfates and halide ions, in particular chloride.
  • Suitable cationic polymers are, for example, copolymers of the formula (Copo) which are preferably present in the hair treatment compositions according to the invention in an amount of from 0.001 to 5% by weight, preferably 0.0025 to 2.5% by weight, based on their weight. more preferably 0.005 to 1 wt .-%, more preferably 0.0075 to 0.75 wt .-% and in particular 0.01 to 0.5 wt .-% are included.
  • Q is from 3 to 55,000, preferably from 10 to 25,000, particularly preferably from 50 to 15,000, more preferably from 100 to 10,000, even more preferably from 500 to 8000 and in particular from 1000 to 5000,
  • x stands for (0 to 0.5) Q, preferably for (0 to 0.3) Q and in particular for the values 0, 1, 2, 3, 4, 5, wherein the value 0 is preferred,
  • y stands for (0.1 to 0.95) Q, preferably for (0.5 to 0.7) Q and in particular for values of 1 to 24000, preferably of 5 to 15000, particularly preferably of 10 to 10000 and in particular of 100 to 4800,
  • hair treatment compositions according to the invention are preferred, which are characterized in that the ratio of (y: z) 4: 1 to 1: 2, preferably 4: 1 to 1 : 1 is.
  • hair treatment compositions according to the invention are preferred in which the copolymer has a molecular weight of 10,000 to 20 million gmol " , preferably from 100,000 to 10 million gmol 1 , on preferably from 500,000 to 5 million gmo and in particular from 1, 1 million to 2.2 million gmol " has.
  • a most preferred copolymer, constructed as previously shown, is commercially available under the name Polyquaternium-74.
  • a particularly suitable homopolymer is the optionally crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium 37.
  • Such products are, for example, under the names Rheocare ® CTH (Cosmetic Rheologies) and Synthalen ® CR (3V Sigma) are commercially available.
  • the homopolymer is preferably used in the form of a non-aqueous polymer dispersion.
  • Such polymer dispersions are available under the names Salcare ® SC 95 and Salcare ® SC 96 in the trade.
  • Suitable cationic polymers derived from natural polymers are cationic derivatives of polysaccharides, for example, cationic derivatives of cellulose, starch or guar. Also suitable are chitosan and chitosan derivatives. Cationic polysaccharides have the general formula G-O-B-N + R a R b R c A "
  • G is an anhydroglucose residue, for example starch or cellulose anhydroglucose
  • B is a divalent linking group, for example alkylene, oxyalkylene, polyoxyalkylene or
  • R a , R b and R c are independently alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or alkoxyaryl each having up to 18 carbon atoms, wherein the total number of carbon atoms in R a , R b and R c is preferably not more than 20 is;
  • a " is a common counteranion and is preferably chloride.
  • Cationic, ie quaternized celluloses are available on the market with varying degrees of substitution, cationic charge density, nitrogen content and molecular weights.
  • Polyquaternium-67 is commercially available under the designations SL ® polymer or polymer ® SK (Amerchol) is. Under the trade designation Mirustyle CP ® of the company. Croda another most preferred cellulose is available. This is a trimonium and cocodimonium hydroxyethylcellulose as derivatized cellulose with the INCI name Polyquaternium-72. Polyquaternium-72 can be used pre-dissolved both in solid form and already in aqueous solution.
  • cationic celluloses are Polymer JR ® 400 (Amerchol, INCI name Polyquaternium-10) and polymer Quatrisoft ® LM-200 (Amerchol, INCI name Polyquaternium-24).
  • Other commercial products are the compounds Celquat ® H 100 and Celquat ® L 200.
  • Particularly preferred cationic celluloses are, Polyquaternium-24, Polyquaternium-67 and Polyquaternium-72.
  • Suitable cationic guar derivatives are marketed under the trade name Jaguar ® and have the INCI name guar hydroxypropyltrimonium chloride. Also particularly suitable cationic guar derivatives also by the company. Hercules under the name N-Hance ® commercially. Further cationic guar derivatives are sold by Cognis under the name Cosmedia ® distributed. A preferred cationic guar derivative is the commercial product AquaCat® ® from. Hercules. This raw material is an already pre-dissolved cationic guar derivative. The cationic guar derivatives are preferred according to the invention.
  • a suitable chitosan is sold, for example, by Kyowa Oil & Fat, Japan under the trade name Flonac ®.
  • a preferred chitosan is chitosoniumpyrrolidone is, for example, sold under the name Kytamer ® PC by Amerchol, USA.
  • Further chitosan derivatives are Hydagen® ® CMF, Hydagen® ® HCMF and Chitolam ® NB / 101 freely available under the trade names in the trade.
  • Another group of polymers to be used in accordance with the invention are polymers based on glucose.
  • the following figure shows such a cationic alkyl oligoglucoside.
  • the radicals R independently of one another are a linear or branched C 6 to C 30 alkyl radical, a linear or branched C 6 -C 30 alkenyl radical, preferably the radical R is a radical R selected from: lauryl, myristyl, cetyl, stearyl, Oleyl, behenyl or arachidyl.
  • the radicals R 1 independently of one another are a linear or branched C 6 to C 30 alkyl radical, a linear or branched C 6 to C 30 alkenyl radical, preferably the radical R is a radical selected from: butyl, capryl, caprylyl, octyl, nonyl, decanyl, lauryl, Myristyl, cetyl, stearyl, oleyl, behenyl or arachidyl. More preferably, the radicals R1 are the same.
  • the radicals R1 are selected from technical mixtures of the fatty alcohol cuts of C6 / C8 fatty alcohols, C8 / C10 fatty alcohols, C10 / C12 fatty alcohols, C12 / C14 fatty alcohols, C12 / C18 fatty alcohols, and most preferred are those technical Fatty alcohol cuts of plant origin.
  • the counterion to the cationic charge is a physiologically acceptable anion, for example, halide, methosulfate, phosphate, citrate, tartrate, etc.
  • the counterion is a halide, such as fluoride, chloride, bromide or methosulfate.
  • the anion is chloride.
  • cationic alkyl oligoglucosides are the compounds having the INCI names Polyquaternium-77, Polyquaternium-78, Polyquaternium-79, Polyquaternium-80, Polyquaternium-81 and Polyquaternium-82. Most preferred are the cationic alkyl oligoglucosides designated Polyquaternium-77, Polyquaternium-81 and Polyquaternium-82.
  • Such compounds can be obtained, for example, under the name Poly Suga® Quat from the company Colonial Chemical Inc.
  • the cationic alkyl oligoglucosides are used in a total amount of from 0.01 to 10.0% by weight, preferably from 0.05 to 5.0% by weight, more preferably from 0.1 to 3.0% by weight, and most preferably in amounts from 0.2 to 2.0% by weight, based in each case on the total weight of the composition.
  • more mixtures of cationic alkyl oligoglucosides can be used. In this case, preference is given to using one long-chain and one short-chain cationic alkyl oligoglucoside at the same time.
  • Another preferred cationic polymer may be obtained based on ethanolamine.
  • the polymer is commercially available under the name Polyquaternium-71.
  • This polymer can be obtained, for example, under the name Cola® Moist 300 P from Colonial Chemical Inc.
  • the polyquaternium-71 is used in a total amount of 0.01 to 10.0% by weight, preferably 0.05 to 5.0% by weight, more preferably 0.1 to 3.0% by weight, and most preferably in Amounts of from 0.2 to 2.0% by weight, based in each case on the total weight of the composition. Furthermore, it is particularly preferable to use a cationic alkyl oligoglucoside as shown in the following figure.
  • the radical R 2 is a linear or branched C 6 to C 30 alkyl radical, a linear or branched C 6 -C 30 alkenyl radical, preferably the radical R is a radical R selected from: lauryl, myristyl, cetyl, stearyl, oleyl, Behenyl or arachidyl.
  • the radical R 1 is a linear or branched C 6 to C 30 alkyl radical, a linear or branched C 6 to C 30 alkenyl radical, preferably the radical R 1 is a radical selected from: butyl, capryl, caprylyl, octyl, nonyl, decanyl, lauryl, myristyl, Cetyl, stearyl, oleyl, behenyl or arachidyl.
  • the radical R1 is selected from technical mixtures of the fatty alcohol cuts of C6 / C8 fatty alcohols, C8 / C10 fatty alcohols, C10 / C12 fatty alcohols, C12 / C14 fatty alcohols, C12 / C18 fatty alcohols, and most preferred are those technical Fatty alcohol cuts of plant origin.
  • the subscript n represents a number between 1 and 20, preferably between 1 and 10, more preferably between 1 and 5 and most preferably between 1 and 3.
  • the counterion to the cationic charge, A " is a physiologically acceptable anion, for example halide, methosulfate , Phosphate, citrate, tartrate, etc.
  • the counterion is a halide such as fluoride, chloride, bromide or methosulfate, most preferably the anion is chloride.
  • cationic alkyl oligoglucosides are the compounds having the INCI names laurdimonium hydroxypropyl decylglucosides chlorides, laurdimonium hydroxypropyl lauryl glucosides chlorides, stearyl dimonium hydroxypropyl decyl glucosides chlorides, stearyl dimonium hydroxypropyl lauryl glucosides chlorides, stearyl dimonium hydroxypropyl lauryl glucosides chlorides or cocoglucosides hydroxypropyl trimonium chlorides.
  • Such compounds can be obtained, for example, under the name Suga® Quat from the company Colonial Chemical Inc.
  • the cationic alkyl oligoglucosides are used in a total amount of from 0.01 to 10.0% by weight, preferably from 0.05 to 5.0% by weight, more preferably from 0.1 to 3.0% by weight, and most preferably in amounts from 0.2 to 2.0% by weight, based in each case on the total weight of the composition.
  • more mixtures of cationic alkyl oligoglucosides can be used. In this case, preference is given to using one long-chain and one short-chain cationic alkyl oligoglucoside at the same time.
  • a particularly preferred cationic polymer according to the invention is the copolymer of N-vinylpyrrolidone, N-vinylcaprolactam, N- (3-dimethylaminopropyl) methacrylamide and 3- (Methacryloylamino) propyl-lauiyl-dimethylammonium chloride (INCI name: Polyquaternium-69), which, for example, under the trade name AquaStyle ® 300 (28-32 wt .-% active ingredient in ethanol-water mixture, molecular weight 350000) sold by the company ISP becomes.
  • AquaStyle ® 300 28-32 wt .-% active ingredient in ethanol-water mixture, molecular weight 350000
  • honey for example the commercial product Honeyquat ® 50,
  • Vinylpyrrolidone vinylimidazoliummethochloride copolymers such as those offered under the names Luviquat.RTM ® FC 370, FC 550 and the INCI name Polyquaternium-16 and FC 905 and HM 552,
  • vinylpyrrolidone / dimethylaminoethyl for example vinylpyrrolidone / dimethylaminoethyl copolymer available under the trade names Gafquat ® 755 N and Gafquat ® 734, United States is marketed by Gaf Co. and the INCI - name Polyquaternium-1 1,
  • Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers such as those offered with acrylic acid esters and acrylamides as the third monomer building commercially, for example, under the name Aquaflex ® SF 40.
  • Amphoteric polymers according to the invention are those polymers in which a cationic group is derived from at least one of the following monomers:
  • R -CH CR 2 -CO-Z- (C n H 2n ) -N (+) R 2 R 3 R 4 A (_) (monol)
  • R and R 2 independently of one another represent hydrogen or a methyl group and R 3 , R 4 and R 5 independently of one another represent alkyl groups having 1 to 4 carbon atoms, Z denotes an NH group or an oxygen atom, n denotes an integer of 2 to 5 and A ⁇ _) is the anion of an organic or inorganic acid,
  • R 8 -CH CR 9 -COOH (mono 3)
  • R 8 and R 9 are independently hydrogen or methyl groups.
  • acrylic acid is preferably used as the monomer (ii) for the polymers mentioned.
  • amphoteric polymers are copolymers of at least one monomer (monol) or (mono 2) with the monomer (mono 3), in particular copolymers of the monomers (mono 2) and (mono 3).
  • amphoteric polymers are copolymers of diallyl dimethyl ammonium chloride and acrylic acid. These copolymers are sold under the INCI name Polyquaternium-22, among others, with the trade name Merquat ® 280 (Nalco).
  • amphoteric polymers according to the invention may additionally contain one monomer (mono 4).
  • R 0 and R independently of one another are hydrogen or methyl groups and R 2 is a hydrogen atom or a (C 1 to C 8 ) alkyl group.
  • Amphoteric polymers based on a comonomer (Mono4) which are very particularly preferably used according to the invention are terpolymers of diallyldimethylammonium chloride, acrylamide and acrylic acid. These copolymers are marketed ® under the INCI name Polyquaternium-39, among others, with the trade name Merquat Plus 3330 (Nalco).
  • amphoteric polymers can generally be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.
  • the abovementioned cationic polymers can be used individually or in any desired combinations with one another, with amounts of from 0.01 to 10% by weight, preferably from 0.01 to 7.5% by weight, and very particularly preferably from 0 to 0, 1 to 5.0 wt.% Are included. The very best results are obtained with amounts of 0, 1 to 3.0 wt.%, Based in each case on the total composition of the respective agent.
  • the hair treatment compositions according to the invention also contain, in addition to the combination of active substances according to the invention, further constituents customary in cosmetic compositions. The selection of these ingredients generally depends on the intended use of the hair treatment compositions. In the case of a shampoo, for example, further surface-active substances will be contained.
  • compositions of the invention are also significantly more stable in storage stability. Especially with higher salaries of silicone oils, the stability is significantly improved.
  • Hydroxycarboxylic acids are carboxylic acids which have both at least one carboxy group and at least one hydroxyl group in the molecule.
  • the hydroxycarboxylic acids include the so-called AHA acids and also ⁇ -hydroxycarboxylic acids.
  • the hydroxycarboxylic acid according to the invention is in particular selected from glycolic acid, lactic acid, glyceric acid, malic acid, citric acid, isocitric acid, mandelic acid, tartronic acid, tartaric acid, vanillic acid, salicylic acid, mevalonic acid, ⁇ -hydroxybutyric acid, gallic acid or protocatechuic acid.
  • the hydroxycarboxylic acid is particularly preferably selected from glycolic acid, lactic acid, glyceric acid, malic acid, citric acid, mandelic acid, tartaric acid, vanillic acid and salicylic acid.
  • the hydroxycarboxylic acid is very particularly preferably selected from glycolic acid, lactic acid, malic acid, citric acid, mandelic acid, tartaric acid and vanillic acid. Most preferably, the hydroxycarboxylic acid is selected from malic acid, mandelic acid, tartaric acid and vanillic acid. Of course, mixtures of hydroxycarboxylic acids can be used.
  • compositions of the present invention contain the total hydroxycarboxylic acids in an amount of from 0.01 to 15.0 weight percent, more preferably from 0.01 to 10.0 weight percent, more preferably from 0.1 to 7.5 weight percent, and most preferably in an amount of 0.1 to 5.0% by weight, based in each case on the total composition.
  • ester oils are defined as follows:
  • Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols.
  • the monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and its technical mixtures.
  • fatty alcohol components in the ester oils are isopropyl alcohol, Caproic alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical grade mixtures.
  • isopropyl myristate IPM Rilanit ®
  • isononanoic acid C16-18 alkyl ester Cetiol ® SN
  • 2-ethylhexyl palmitate Cegesoft ® 24
  • stearic acid 2-ethylhexyl ester Cetiol ® 868
  • cetyl oleate glycerol tricaprylate
  • Kokosfettalkohol- caprinatV caprylate (Cetiol ® LC)
  • n-butyl stearate oleyl erucate
  • isopropyl palmitate Rosanit ® IPP
  • oleyl Oleate Cetiol ®
  • hexyl laurate Cetiol ® A
  • di-n-butyl adipate Cetiol ® B
  • myrist IPM Rilanit ®
  • ester oils may also be alkoxylated with ethylene oxide, propylene oxide, or mixtures of ethylene oxide and propylene oxide.
  • the alkoxylation can be found both on the fatty alcohol part and on the fatty acid part and on both parts of the ester oils.
  • R 1 is a saturated or unsaturated, branched or unbranched, cyclic saturated cyclic unsaturated acyl radical having 6 to 30 carbon atoms,
  • AO is ethylene oxide, propylene oxide or butylene oxide
  • X is a number between 1 and 200, preferably 1 and 100, more preferably between 1 and 50, most preferably between 1 and 20, most preferably between 1 and 10 and most preferably between 1 and 5,
  • R 2 represents a saturated or unsaturated, branched or unbranched, cyclic saturated cyclic unsaturated alkyl, alkenyl, alkynyl, phenyl or benzyl radical having from 6 to 30 carbon atoms.
  • fatty acid moieties used as radical R1 in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid , Gadoleic acid, behenic acid and erucic acid and their technical mixtures.
  • ester oils examples include benzyl alcohol, isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol , Arachylalkohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures.
  • a particularly preferred ester oil according to the invention is obtainable, for example, under the INCI name PPG-3 benzyl ether myristate.
  • ester oils are to be understood as meaning:
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,
  • Fatty acid partial glycerides ie monoglycerides, diglycerides and their technical mixtures. Typical examples are mono- and / or diglycerides based on caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, Gadoleic acid, behenic acid and erucic acid and their technical mixtures.
  • oleic acid monoglycerides are used.
  • the ester oils are present in the compositions according to the invention in an amount of from 0.01 to 20% by weight, preferably from 0.01 to 10.0% by weight, particularly preferably from 0.01 to 7.5% by weight, most preferably from 0, 1 to 5.0 wt.% Used.
  • oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
  • the compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) - cyclohexane (Cetiol ® S), and di-n-octyl ether (Cetiol ® OE) may be preferred.
  • the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle.
  • the choice of surfactants depends on the nature of the agent.
  • Suitable anionic surfactants (tanion) in preparations according to the invention are all anionic surfactants suitable for use on the human body. Typical examples of anionic surfactants are:
  • Sulfobernsteinklamono- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
  • Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms are alpha-sulfofatty acids having 8 to 30 carbon atoms.
  • Alkyl sulfates and alkyl polyglycol ether sulfates of the formula R-O (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x 0 or 1 to 12,
  • R 2 is hydrogen, a radical (CH 2 CH 2 0) nR 2 or X, n is from 1 to 10 and X is hydrogen, an alkali or alkaline earth metal or NR 3 R 4 R 5 R 6 , where R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydrocarbon radical,
  • RCO-- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 C atoms
  • Alk for CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3
  • n for numbers of 0 , 5 to 5 and M is a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or ammonium ion, such as + NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another represent hydrogen or a C1 to C4 hydrocarbon radical
  • R 8 CO is a linear or branched acyl radical having 6 to 22 carbon atoms
  • x, y and z are in total 0 or numbers of 1 to 30, preferably 2 to 10
  • X is an alkali or alkaline earth metal.
  • monoglyceride ether sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts.
  • monoglyceride sulfates are used, in which R 8 CO is a linear acyl radical having 8 to 18 carbon atoms,
  • Amide ether carboxylic acids R-CO-NR 2 -CH 2 CH 2 -0- (CH 2 CH 2 0) n CH 2 COOM, with R as a straight-chain or branched alkyl or alkenyl radical with a number of carbon atoms in the chain 2-30 , n is an integer from 1 to 20 and R 2 is hydrogen, a methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl or iso-butyl radical and M is hydrogen or a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or an ammonium ion, such as + NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another for hydrogen or a C1 to C4 - hydrocarbon radical.
  • Such products are obtainable, for example, by the company Chem Y under the product name Akypo ®.
  • Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate with a C8-C30 fatty acid are available under the trademark Lamepon® ®, Maypon ®, Gluadin® ®, Hostapon® ® KCG or Amisoft ® long been commercially.
  • the mild anionic surfactants contain polyglycol ether chains, it is particularly preferred that they have a narrow homolog distribution. Further, in the case of mild anionic surfactants having polyglycol ether units, it is preferable that the number of glycol ether groups is 1 to 20, preferably 2 to 15, more preferably 2 to 12. Particularly mild anionic surfactants having polyglycol ether groups with no restricted homolog distribution can be obtained, for example on the one hand the number of polyglycol ether groups is 4 to 12 and Zn or Mg ions are selected as the counterion. One example is the commercial product Texapon.RTM ® ASV.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • Ampholytic surfactants are understood as meaning those surface-active compounds which are capable of forming internal salts.
  • suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkylimino-dipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group.
  • amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and the d 2 -C 8 -acylsarcosine.
  • Nonionic surfactants are for example Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide onto linear and branched fatty alcohols having 6 to 30 carbon atoms, the fatty alcohol polyglycol ethers or the fatty alcohol polypropyleneglycol ethers or mixed fatty alcohol polyethers,
  • R is CO for a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms
  • R 2 is hydrogen or methyl
  • R 3 is linear or branched alkyl radicals having 1 to 4 carbon atoms
  • w is a number from 1 to 20 .
  • R 0 [CH 2 CH (CH 3 ) O] x (CH 2 CHR 2 O) y [CH 2 CH (OH) R 3 ] z with R standing for a linear or branched, saturated or unsaturated alkyl and / or or alkenyl radical having 2 to 30 C atoms
  • R 2 is hydrogen, a methyl, ethyl, propyl or iso-propyl radical
  • R 3 is a linear or branched alkyl radical having 2 to 30 C atoms
  • x is 0 or a number from 1 to 20
  • Y stands for a number from 1 to 30
  • z stands for the number 1, 2, 3, 4 or 5.
  • Fatty acid amide polyglycol ethers Fatty acid amide polyglycol ethers, fatty amine polyglycol ethers,
  • the surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention ,
  • Emulsifiers which can be used according to the invention are, for example
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols both from animal tissue (zoosterols, cholesterol, lanosterol) and from plant fats (phytosterols, ergosterol, stigmasterol, sitosterol) or from fungi and yeasts (mycosterols),
  • Phospholipids lecithins, phopshatidylcholines
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol
  • Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1 to 25% by weight, in particular 0.5 to 15% by weight, based on the total agent.
  • compositions according to the invention contain fatty substances (fat) as further active ingredient.
  • Fat substances (fat) are understood to mean fatty acids, fatty alcohols, natural and synthetic waxes, which can be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • fatty acids (Fatac) can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms.
  • isostearic as the commercial products Emersol ® 871 and Emersol ® 875
  • isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • Further typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic as well as their technical mixtures.
  • Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean.
  • the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
  • fatty alcohols fatal
  • saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 -C 30 -, preferably C 10 -C 22 -and very particularly preferably C 12 -C 22 -carbon atoms.
  • Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character.
  • the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
  • those fatty alcohol cuts which represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Is
  • wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
  • the fatty alcohols are used in amounts of 0.1 to 30% by weight, based on the total preparation, preferably in amounts of 0.1 to 20% by weight.
  • waxes can be used according to the invention are solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or Citrus wax, Microwachse from PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the amount used is 0, 1-50 wt.% Based on the total agent, preferably 0, 1 to 20 wt.% And particularly preferably 0, 1 to 15 wt.% Based on the total agent.
  • the total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.
  • compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (P).
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) and kerasol tm ® (Croda) sold.
  • Further preferred vegetable protein hydrolysates according to the invention are, for example, soybean, almond, pea, moringa, potato and wheat protein hydrolysates.
  • Such products are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda), hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda), Crotein ® (Croda) and Puricare ® LS 9658 from Laboratoires Serobi unanimouss.
  • protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates.
  • pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ® or Crodarom ® Pearl.
  • cationized protein hydrolysates are to be counted among the protein hydrolysates and their derivatives, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, maize, rice, potatoes, soya or almonds, from marine life forms , for example from fish collagen or algae, or biotechnologically derived protein hydrolysates, may originate.
  • the cationic protein hydrolysates and derivatives according to the invention those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1 101 17 th Street, NW, Suite 300, Washington, DC 20036-4702) and commercially available products.
  • the protein hydrolysates (P) are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight. up to 5% by weight.
  • Another preferred group of ingredients of the compositions according to the invention with the active ingredient complex according to the invention are vitamins, provitamins or vitamin precursors. Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
  • vitamin A The group of substances referred to as vitamin A include retinol (vitamin A-1) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration.
  • the agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • the vitamin B group or the vitamin B complex include u. a .:
  • Vitamin B 2 (riboflavin)
  • Vitamin B 3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
  • Vitamin B 5 pantothenic acid, panthenol and pantolactone.
  • Panthenol and / or pantolactone are preferably used in the context of this group.
  • Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are, for example, panthenol triacetate, panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives.
  • Pantothenic acid is preferably used as a derivative in the form of the more stable calcium salts and sodium salts (Ca-pantothenate, Na-pantothenate) in the present invention.
  • Vitamin B 6 pyridoxine and pyridoxamine and pyridoxal.
  • the said compounds of the vitamin B type are preferably present in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0, 1-5 wt .-% are particularly preferred.
  • Vitamin C (ascorbic acid). Vitamin C is used in the inventive compositions preferably in amounts of 0, 1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
  • Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.
  • compositions according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.
  • a particularly preferred group of ingredients in the cosmetic compositions according to the invention are the following betaines: carnitine, carnitine tartrate, carnitine magnesium citrate, acetyl carnitine, betalain, 1, 1-dimethyl-proline, choline, choline chloride, choline bitartrate, choline dihydrogen citrate and in the literature as Betaine designated compound ⁇ , ⁇ , ⁇ -trimethylglycine.
  • Carnitine, histidine, choline and betaine are preferably used.
  • the active ingredient used is L-carnitine tartrate.
  • agents according to the invention which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and in particular 0.001 to 1, 0 wt .-% of at least one of the aforementioned betaines, in particular carnitine tartrate.
  • compositions according to the invention contain biochinones.
  • suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s).
  • the preferred ubiquinones according to the invention have the following formula:
  • Coenzyme Q-10 is most preferred.
  • compositions of the invention contain purine and / or purine derivatives in narrower ranges.
  • inventively preferred cosmetic agents characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • Cosmetic agents preferred according to the invention are characterized in that they contain purine, adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine, caffeine, theobromine or theophylline. In hair cosmetic preparations, caffeine is most preferred.
  • the cosmetic agent contains ectoine ((S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid.
  • ectoine ((S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid.
  • agents which, based on their weight, are from 0.00001 to 10.0% by weight, preferably from 0.0001 to 5.0% by weight and in particular from 0.001 to 3% by weight, of the active compounds from Group formed by carnitine, coenzyme Q-10, ectoine, a vitamin B series, a purine and its derivatives or physiologically acceptable salts.
  • a particularly preferred care additive in the hair treatment compositions according to the invention is taurine.
  • Taurine is understood to mean exclusively 2-aminoethanesulfonic acid and a derivative to the explicitly mentioned derivatives of taurine.
  • Derivatives of taurine include N-monomethyltaurine, ⁇ , ⁇ -dimethyltaurine, tauryllysylate, taurine tartrate, taurine ornithine, lysyl taurine and ornithyl taurine.
  • agents according to the invention which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and In particular, 0.001 to 1, 0 wt .-% taurine and / or a derivative of taurine included.
  • the effect of the compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J).
  • the sodium salt is most preferred.
  • the amounts used in the inventive compositions are 0.05 to 10 wt.%, Based on the total agent, particularly preferably 0, 1 to 5, and in particular 0.1 to 3 wt.%.
  • the hair treatment compositions according to the invention can be formulated in a particularly natural and yet very effective way in their care performance.
  • customary preservatives can be dispensed with.
  • the agents according to the invention should additionally contain at least one UV light protection filter.
  • UVB filters can be oil-soluble or water-soluble.
  • oil-soluble substances are e.g. to call:
  • 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and 4- (dimethylamino) benzoic acid ester;
  • Esters of cinnamic acid preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester, 2-cyano-3-phenyl-cinnamic acid 2-ethylhexyl ester (octocrylene);
  • Esters of salicylic acid preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • Esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate
  • Triazine derivatives e.g. 2,4,6-Trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine and
  • Propane-1,3-diones e.g. 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione;
  • Suitable water-soluble substances are:
  • Sulfonic acid derivatives of the 3-benzylidene camphor e.g. 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) -sulfonic acid and its salts.
  • UV-A filter in particular derivatives of benzoylmethane are suitable, such as, for example, 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione or 1-phenyl-3 (4'-isopropylphenyl) -propane-1,3-dione.
  • the UV-A and UV-B filters can also be used in mixtures.
  • insoluble pigments in particular finely dispersed metal oxides or salts, are suitable for this purpose, for example titanium dioxide, zinc oxide, iron oxide, aluminum oxide, cerium oxide, zirconium oxide, silicates (talc), barium sulfate and zinc stearate.
  • titanium dioxide zinc oxide
  • iron oxide aluminum oxide
  • cerium oxide cerium oxide
  • zirconium oxide silicates (talc)
  • barium sulfate and zinc stearate.
  • These pigments are preferred according to the invention, in particular as part of a mixture of a plurality of structurally different UV filters.
  • the particles should be one average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They may have a spherical shape, but it is also possible to use those particles which have an ellipsoidal or otherwise deviating shape from the spherical shape.
  • the total amount of UV filter substances in the compositions according to the invention is in each case 0.01 to 15.0% by weight, preferably 0.01 to 10.0% by weight, more preferably 0.1 to 10.0% by weight, relative to the total composition %, more preferably from 0.2 to 10.0% by weight, and most preferably from 0.3 to 10.0% by weight.
  • anionic polymers examples include acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for all or some of the sulfonic acid group to be present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,
  • the homopolymer of 2-acrylamido-2-methylpropansulfon acid which is commercially available, for example under the name Rheothik ® 1 1-80 is.
  • Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
  • Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers.
  • a 1, 9-decadiene crosslinked maleic acid methyl vinyl ether copolymer is available under the name ® Stabileze QM.
  • the anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0, 1 to 5 wt .-% are particularly preferred.
  • the agents according to the invention may contain nonionogenic polymers.
  • Suitable nonionic polymers are, for example: Vinylpyrrolidone / vinyl ester copolymers, as sold, for example, under the trademark Luviskol ® (BASF). Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALON) and Natrosol ® grades (Hercules).
  • Starch and its derivatives in particular starch, such as Structure XL ® (National Starch), a multifunctional, salt-tolerant starch;
  • the nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0, 1 to 5 wt .-% are particularly preferred.
  • the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as
  • Structurants such as maleic acid and lactic acid
  • Swelling agents such as urea, allantoin, carbonates or hydantoin
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, C0 2 and air,
  • a second subject of the invention is a method for hair treatment, in which a hair treatment composition according to claim 1 is applied to the hair and is rinsed by the hair after a contact time.
  • the exposure time is preferably a few seconds to 100 minutes, more preferably 1 to 50 minutes and most preferably 1 to 30 minutes.
  • a cosmetic composition according to claim 1 is applied to the hair and remains there.
  • “remaining on the hair” is understood according to the invention that the agent not immediately after its application again is rinsed out of the hair. Rather, the agent remains in this case more than 100 minutes until the next hair wash on the hair.
  • the pH of all formulations was adjusted to 4.5 to 5.8.
  • Thickeners which can be used are all thickeners or thickener systems known to the person skilled in surfactant systems. Cellulose ethers, xanthan gum, hydroxyethyl celluloses, laureth-2 and laureth-3, and for example the products under the trade name Antil® or Crothix® are each used individually or in mixtures with one another, for example in the aforementioned formulations.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne des agents de soins capillaires contenant une combinaison synergique composée de silicones choisis et de complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques.
EP13734093.1A 2012-08-09 2013-07-05 Agents de soins capillaires contenant des silicones choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques Ceased EP2882406A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012214141.3A DE102012214141A1 (de) 2012-08-09 2012-08-09 Haarbehandlungsmittel enthaltend ausgewählte Silikone und ausgewählte Komplexe aus sauren Proteinhydrolysaten und basischen Fettsäureamidoaminen
PCT/EP2013/064213 WO2014023488A2 (fr) 2012-08-09 2013-07-05 Agents de soins capillaires contenant des silicones choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques

Publications (1)

Publication Number Publication Date
EP2882406A2 true EP2882406A2 (fr) 2015-06-17

Family

ID=48746538

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13734093.1A Ceased EP2882406A2 (fr) 2012-08-09 2013-07-05 Agents de soins capillaires contenant des silicones choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques

Country Status (4)

Country Link
US (1) US20150144151A1 (fr)
EP (1) EP2882406A2 (fr)
DE (1) DE102012214141A1 (fr)
WO (1) WO2014023488A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013224999A1 (de) * 2013-12-05 2015-06-11 Henkel Ag & Co. Kgaa Haarbehandlungsmittel mit substituierten Silikon(en)
DE102017223103A1 (de) * 2017-12-18 2019-06-19 Henkel Ag & Co. Kgaa Haarbehandlungsmittel enthaltend sulfatierte oder sulfonierte Öle und Amidoamine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2596985B1 (fr) * 1986-04-10 1990-08-24 Oreal Compositions cosmetiques pour teindre ou pour decolorer les cheveux
US5188756A (en) * 1991-08-07 1993-02-23 Kolmar Laboratories, Inc. Topical cleansing and conditioning composition
DE102006032505A1 (de) * 2006-07-12 2008-01-17 Henkel Kgaa Anti-Schuppen-Shampoo
EP1880707A1 (fr) * 2006-07-21 2008-01-23 Wella Aktiengesellschaft Méthode et agent pour la déformation permanente de cheveux
DE102006035512A1 (de) 2006-07-31 2008-02-07 Evonik Goldschmidt Gmbh Neuartige Polysiloxane mit quaternären Ammoniumgruppen, Verfahren zu deren Herstellung und deren Verwendung in reinigenden und pflegenden Formulierungen
DE102006050650A1 (de) * 2006-10-24 2008-04-30 Henkel Kgaa Leistungsgesteigerte kosmetische Mittel, insbesondere Haarbehandlungsmittel mit Polymeren
DE102006051729A1 (de) * 2006-10-30 2008-05-08 Henkel Kgaa Kosmetisches Mittel
DE102008019340A1 (de) * 2008-04-16 2009-10-22 Henkel Ag & Co. Kgaa Haarbehandlungsmittel mit Cloudberry-Fruchtextrakt
MX2010014377A (es) * 2008-06-25 2011-02-22 Procter & Gamble Composicion acondicionadora del cabello que contiene cloruro de cetiltrimetilamonio.
DE102010063923A1 (de) * 2010-12-22 2012-06-28 Henkel Ag & Co. Kgaa Haarbehandlungsmittel
CN102834088A (zh) * 2011-04-12 2012-12-19 株式会社成和化成 化妆品基材以及含有该化妆品基材的化妆品

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2014023488A3 *

Also Published As

Publication number Publication date
DE102012214141A1 (de) 2014-02-13
WO2014023488A2 (fr) 2014-02-13
WO2014023488A3 (fr) 2014-10-09
US20150144151A1 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
WO2014090520A1 (fr) Agents de soins capillaires contenant des agents antipelliculaires et des silicones selectionnees contenant des structures glucidiques
DE102012219585A1 (de) Haarpflegemittel mit ausgewählten Aminosäuren und/oder ausgewählten Oligopeptiden und einem ausgewählten kationischen Keratinhydrolysat
WO2013143776A2 (fr) Agents de traitement capillaire contenant des amides d'acides gras sélectionnés et des composés d'ammoniums quaternaires sélectionnés
EP2830581A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des filtres uv sélectionnés
DE102012203986A1 (de) Haarbehandlungsmittel enthaltend Cyperus esculentus tuber oil
EP2830577A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des corps gras sélectionnés
DE102012219581A1 (de) "Haarpflegemittel mit ausgewählten kationischen Alkyloligoglucosiden und einem ausgewählten kationischen Keratinhydrolysat"
DE102010062639A1 (de) Haarbehandlungsmittel enthaltend Ximenia-Öl
DE102010062640A1 (de) Haarbehandlungsmittel enthaltend Mongongo-Öl
EP2830580A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des silicones sélectionnés
EP2830576A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des acides hydroxycarboxyliques sélectionnés
WO2013143735A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des composés d'ammonium quaternaire
DE102012203989A1 (de) Haarbehandlungsmitel enthaltend Cyperus esculentus tuber extract
EP2882406A2 (fr) Agents de soins capillaires contenant des silicones choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques
DE102010062638A1 (de) Haarbehandlungsmittel enthaltend Baobab-Öl
WO2013127612A2 (fr) Produits capillaires contenant des alkyloligoglucosides cationiques sélectionnés et d'autres composés ammonium quaternaires sélectionnés
WO2014023533A2 (fr) Agents de soins capillaires contenant des agents anti-pelliculaires et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques
EP2809296A2 (fr) Produits capillaires contenant des alkyloligoglucosides cationiques sélectionnés et d'autres composés d'ammonium quaternaires
DE102011085215A1 (de) Haarbehandlungsmittel enthaltend Kamutprotein
WO2014023509A2 (fr) Agents de soins capillaires contenant des filtres à uv choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques
DE102015220547A1 (de) Haarbehandlungsmittel enthaltend Murumurubutter
WO2014023491A2 (fr) Agents de soins capillaires contenant des composés ammonium quaternaires choisis et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques
WO2013127613A2 (fr) Produits capillaires contenant des alkyloligoglucosides cationiques sélectionnés et des silicones cationiques sélectionnées
DE102011085216A1 (de) Haarbehandlungsmittel enthaltend ausgewählte Gemüseextrakte
DE102010062641A1 (de) Haarbehandlungsmittel enthaltend Kankaextrakt

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150107

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20160114

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20160623